ATE386747T1 - Antikörper gegen ep-cam - Google Patents

Antikörper gegen ep-cam

Info

Publication number: ATE386747T1
Authority: AT; Austria
Prior art keywords: cam; library; antibodies against; epitope; selecting
Prior art date: 1999-12-27

Application number

AT02077516T

Other languages

English (en)

Inventor

Ton Logtenberg

Original Assignee

Crucell Holland Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-27

Filing date

2000-12-21

Publication date

2008-03-15

2000-12-21 Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv

2008-03-15 Application granted granted Critical

2008-03-15 Publication of ATE386747T1 publication Critical patent/ATE386747T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT02077516T 1999-12-27 2000-12-21 Antikörper gegen ep-cam ATE386747T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99204561		1999-12-27

Publications (1)

Publication Number	Publication Date
ATE386747T1 true ATE386747T1 (de)	2008-03-15

Family

ID=8241110

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT00991344T ATE366419T1 (de)	1999-12-27	2000-12-21	Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
AT02077516T ATE386747T1 (de)	1999-12-27	2000-12-21	Antikörper gegen ep-cam
AT04102692T ATE353920T1 (de)	1999-12-27	2000-12-21	Menschlischer monoklonaler antikörper gegen ep- cam und dessen verwendung in krebstherapie

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT00991344T ATE366419T1 (de)	1999-12-27	2000-12-21	Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT04102692T ATE353920T1 (de)	1999-12-27	2000-12-21	Menschlischer monoklonaler antikörper gegen ep- cam und dessen verwendung in krebstherapie

Country Status (11)

Country	Link
US (2)	US20030096225A1 (de)
EP (3)	EP1273918B1 (de)
JP (1)	JP2003518391A (de)
AT (3)	ATE366419T1 (de)
AU (1)	AU783148B2 (de)
CA (1)	CA2396029A1 (de)
DE (3)	DE60038132T2 (de)
DK (1)	DK1479696T3 (de)
ES (1)	ES2282797T3 (de)
NZ (2)	NZ520074A (de)
WO (1)	WO2001048485A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7658924B2 (en)	2001-10-11	2010-02-09	Amgen Inc.	Angiopoietin-2 specific binding agents
US7521053B2 (en)	2001-10-11	2009-04-21	Amgen Inc.	Angiopoietin-2 specific binding agents
MXPA04010222A (es) *	2002-04-17	2005-03-07	Roberto Crea	Dopacion en mutagenesis en ruta.
USRE47770E1 (en)	2002-07-18	2019-12-17	Merus N.V.	Recombinant production of mixtures of antibodies
EP2314629B2 (de)	2002-07-18	2022-11-16	Merus N.V.	Rekombinante Herstellung von Mischungen aus Aantikörpern
WO2004106375A1 (en)	2003-05-30	2004-12-09	Merus Biopharmaceuticals B.V. I.O.	Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en)	2008-06-27	2010-03-18	Merus B.V.	Antibody producing non-human mammals
EP2374465A1 (de) *	2003-09-08	2011-10-12	E. I. du Pont de Nemours and Company	Pflegespülung auf Peptidbasis und Färbemittel für Haar, Haut und Nägel
AU2005205412B2 (en)	2004-01-20	2011-08-11	Merus N.V.	Mixtures of binding proteins
JO2913B1 (en)	2008-02-20	2015-09-15	امجين إنك,	Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US9079942B2 (en)	2009-02-09	2015-07-14	Epitomics, Inc.	CDR-anchored amplification method
GB0909904D0 (en)	2009-06-09	2009-07-22	Affitech As	Product
US8293483B2 (en)	2009-09-11	2012-10-23	Epitomics, Inc.	Method for identifying lineage-related antibodies
CN110763842A (zh)	2011-06-29	2020-02-07	中央研究院	使用表面涂层对生物物质的捕获、纯化和释放
CA2791109C (en)	2011-09-26	2021-02-16	Merus B.V.	Generation of binding molecules
CN104168916B (zh) *	2012-03-02	2017-07-04	中央研究院	抗上皮细胞黏着分子(EpCAM)抗体及其使用方法
DK2838918T3 (da)	2012-04-20	2019-08-12	Merus Nv	Fremgangsmåder og midler til fremstilling af heterodimere ig-lignende molekyler
CN106662514A (zh)	2014-04-01	2017-05-10	中央研究院	用于癌症诊断及预后的方法和系统
CN105381824B (zh)	2014-08-26	2019-04-23	中央研究院	收集器架构布局设计
US10107726B2 (en)	2016-03-16	2018-10-23	Cellmax, Ltd.	Collection of suspended cells using a transferable membrane
US20210246519A1 (en) *	2018-05-04	2021-08-12	The Regents Of The University Of California	Spiked primers for enrichment of pathogen nucleic acids among background of nucleic acids
CN115397867A (zh) *	2020-04-13	2022-11-25	艾弗依姆恩治疗公司	Epcam抗体与car-t细胞
CN116600819A (zh) *	2020-12-09	2023-08-15	艾弗依姆恩治疗公司	靶向epcam和icam-1的双嵌合抗原受体
WO2023174521A1 (en)	2022-03-15	2023-09-21	Genmab A/S	Binding agents binding to epcam and cd137
WO2025056180A1 (en)	2023-09-15	2025-03-20	BioNTech SE	Methods of treatment using agents binding to epcam and cd137 in combination with pd-1 axis binding antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5605793A (en) *	1994-02-17	1997-02-25	Affymax Technologies N.V.	Methods for in vitro recombination
US6265150B1 (en) *	1995-06-07	2001-07-24	Becton Dickinson & Company	Phage antibodies
JP2001512560A (ja) *	1996-10-08	2001-08-21	ユー―ビスイスベスローテンフェンノートシャップ	標的に対し特異的な親和性を有するペプチドおよびタンパク質の選択のための方法および手段
US6787638B1 (en) *	1998-12-02	2004-09-07	Applied Molecular Evolution, Inc.	Tumor specific human monoclonal antibodies and methods of use

2000
- 2000-12-21 CA CA002396029A patent/CA2396029A1/en not_active Abandoned
- 2000-12-21 AU AU32447/01A patent/AU783148B2/en not_active Ceased
- 2000-12-21 AT AT00991344T patent/ATE366419T1/de not_active IP Right Cessation
- 2000-12-21 EP EP02077516A patent/EP1273918B1/de not_active Expired - Lifetime
- 2000-12-21 NZ NZ520074A patent/NZ520074A/en unknown
- 2000-12-21 EP EP00991344A patent/EP1242823B1/de not_active Expired - Lifetime
- 2000-12-21 AT AT02077516T patent/ATE386747T1/de not_active IP Right Cessation
- 2000-12-21 DK DK04102692T patent/DK1479696T3/da active
- 2000-12-21 ES ES04102692T patent/ES2282797T3/es not_active Expired - Lifetime
- 2000-12-21 WO PCT/NL2000/000941 patent/WO2001048485A2/en not_active Ceased
- 2000-12-21 DE DE60038132T patent/DE60038132T2/de not_active Expired - Lifetime
- 2000-12-21 DE DE60035434T patent/DE60035434T2/de not_active Expired - Lifetime
- 2000-12-21 JP JP2001549082A patent/JP2003518391A/ja not_active Withdrawn
- 2000-12-21 AT AT04102692T patent/ATE353920T1/de active
- 2000-12-21 DE DE60033455T patent/DE60033455T2/de not_active Expired - Lifetime
- 2000-12-21 NZ NZ531590A patent/NZ531590A/en unknown
- 2000-12-21 EP EP04102692A patent/EP1479696B1/de not_active Expired - Lifetime
2002
- 2002-06-27 US US10/184,508 patent/US20030096225A1/en not_active Abandoned
- 2002-06-28 US US10/186,186 patent/US7777010B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1273918B1 (de)	2008-02-20
AU3244701A (en)	2001-07-09
DE60038132D1 (de)	2008-04-03
JP2003518391A (ja)	2003-06-10
DK1479696T3 (da)	2007-05-07
DE60033455D1 (de)	2007-03-29
CA2396029A1 (en)	2001-07-05
EP1242823A2 (de)	2002-09-25
EP1273918A2 (de)	2003-01-08
EP1479696A1 (de)	2004-11-24
AU783148B2 (en)	2005-09-29
EP1242823B1 (de)	2007-07-04
NZ531590A (en)	2006-01-27
ATE366419T1 (de)	2007-07-15
WO2001048485A3 (en)	2002-01-31
US20030096225A1 (en)	2003-05-22
EP1479696B1 (de)	2007-02-14
EP1273918A3 (de)	2003-05-02
ATE353920T1 (de)	2007-03-15
US7777010B2 (en)	2010-08-17
DE60035434D1 (de)	2007-08-16
DE60035434T2 (de)	2008-05-15
DE60033455T2 (de)	2007-11-29
WO2001048485A9 (en)	2002-09-06
ES2282797T3 (es)	2007-10-16
WO2001048485A2 (en)	2001-07-05
US20030096226A1 (en)	2003-05-22
NZ520074A (en)	2004-04-30
DE60038132T2 (de)	2009-04-02

Legal Events

Date	Code	Title	Description
2008-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60038132D1 (de)	2008-04-03	Antikörper gegen Ep-Cam
AU5632700A (en)	2001-01-09	System for sound file recording, analysis, and archiving via the internet for language training and other applications
DE69424019D1 (de)	2000-05-25	System zur Sprachlichen Wiedergabe von Hypertextdokumenten, wie Hilfsdateien
ATE211552T1 (de)	2002-01-15	Immunoassay für h. pylori in fäkalienproben
ID16966A (id)	1997-11-27	Sediaan antibodi pekat
WO2002086083A3 (en)	2003-02-27	Methods of enhancing cell responsiveness
EP0899665A3 (de)	2001-05-02	Durchsuchen von Dokumenten mit mehreren Elementtypen
WO2005052751A3 (en)	2006-11-23	Light system manager
EP2302382A3 (de)	2011-10-05	Docetaxel Konjugaten und Immunogenen zur Verwendung in einem Immunassay
BR9802456B1 (pt)	2009-01-13	aparelho, e, processo para obtenção de parafinas ou frações de parafinas.
ATE286073T1 (de)	2005-01-15	Antikörper gegen spaltprodukte von vimentin
PT840620E (pt)	2002-04-29	Antagonistas de il-8 para o tratamento de asma
SE9802264D0 (sv)	1998-06-25	A method of isolating cells
TR200003467T2 (tr)	2001-04-20	Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
ATE250128T1 (de)	2003-10-15	Treponema palladium fusions-antigen, nachweis für anti-treponema palladium antikörpern mit diesen fusions-antigenen
HK1046925A1 (zh)	2003-01-30	Mage-a12抗原肽及其用途
WO2003027236A3 (en)	2006-02-23	Systems, methods and kits for remote genetic analysis and consultation
NL1007374A1 (nl)	1998-05-06	Aftastende omgevings-elektronenmicroscoop.
TR27897A (tr)	1995-10-11	Etanol ve izopropanol üretmeye mahsus yöntem.
WO2000073345A3 (en)	2001-05-25	Antibodies specific for mycobacterial polypeptides and uses thereof
NL1004554A1 (nl)	1997-06-24	Compacte fluorescerende lamp en een werkwijze voor het vervaardigen daarvan.
NL1001288A1 (nl)	1996-04-01	Werkwijze en inrichting voor het vervaardigen van een optische schijf van organisch materiaal.
DE69927801D1 (de)	2005-11-24	Bodentest
WO2003009887A3 (en)	2003-09-18	Immuno absorption columns for the subtraction of antibodies from blood with selective plasmafiltration techniques
ATE342277T1 (de)	2006-11-15	Neuer transkriptionsfaktor carp-2